Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Caplin Point Laboratories Ltd.
NSE: CAPLIPOINT
|
BSE: 524742
|
ISIN: INE475E01026
|
Industry: Pharmaceuticals
Board Meeting
|
Expensive Performer
1860.9000
-40.90
(
-2.15
%)
NSE
May 09, 2025
15:31 PM
29.54% Fall from 52W High
Volume:
62,212
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Caplin Point Laboratories Ltd.
08 Aug 2024
Board Meeting
1860.90
-2.15%
Caplin Point Laboratories
Buy:
Caplin Point Laboratories ...
by
ICICI Direct
Target: 1980 | Target met
Target
ICICI Direct
Number of FII/FPI investors increased from 155 to 177 in Mar 2025 qtr.
More from Caplin Point Laboratories Ltd.
Recommended
Five Interesting Stocks Today - May 09, 2025
The Baseline |
09 May 2025, 04:56PM
Market closes lower, Intellect Design Arena's Q4 net profit surges 93% QoQ to Rs 135.3 crore
Trendlyne Marketwatch |
09 May 2025, 03:56PM
Caplin Point Laboratories maintains export momentum, expands ambitions to new markets
|
01 Jul 2022